Covington represented the placement agents on the deal. Immunic, Inc. (Nasdaq: IMUX) (“Immunic” or the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of selective oral...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the underwriters in the offering. Gamida Cell Ltd. announced the $20 million SEC-registered follow-on offering of 12,905,000 ordinary shares. The ordinary shares...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. First Watch Restaurant Group, Inc. (NASDAQ: FWRG), the Daytime Dining concept serving breakfast, brunch and lunch, has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented AIG in the transaction, while Cleary Gottlieb represented the underwriters. Debevoise & Plimpton advised Corebridge Financial. American International Group, Inc....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Oak Street Health, Inc. announced the $180.3 million secondary offering of 7,000,000 million shares of common stock...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Portillo’s Inc. (Nasdaq: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, closed on...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Amgen in the offerings, while Shearman & Sterling represented represented the underwriters. Amgen Inc. executed a senior unsecured notes offerings consisting of US$1,250,000,000 4.050%...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Evertec, while Simpson Thacher represented the underwriters, led by J.P. Morgan Securities in the offering. Popular, Inc. (the “Selling Stockholder”) announced the secondary offering...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...
You must be a Standard 1 Year member to access this content.
Homburger advised VectivBio on the deal. NKF acted as Swiss counsel to SVB Securities, Piper Sandler and LifeSci Capital in the public offering. VectivBio Holding AG (Nasdaq:...
You must be a Standard 1 Year member to access this content.
